GlaxoSmithKline plc EV 2011-2026 | GSK

EV Jährlich GlaxoSmithKline plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
41.8 B	42.5 B	43.3 B	46.3 B	260 B	131 B	145 B	134 B	14.1 B	35.8 B	55.2 B	70.1 B	91.2 B	77.3 B	81 B

Alle Zahlen in GBP-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
260 B	14.1 B	84.6 B

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Cabaletta Bio CABA	253 M	$ 2.82	1.44 %	$ 283 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Esperion Therapeutics ESPR	1.16 B	$ 2.85	3.26 %	$ 592 M	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Equillium EQ	91.1 M	$ 2.06	-	$ 118 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.29	-3.01 %	$ 329 M	Britain
Stoke Therapeutics STOK	1.99 B	$ 33.7	-0.27 %	$ 2 B	USA
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Heron Therapeutics HRTX	411 M	$ 0.83	3.62 %	$ 138 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Savara SVRA	1.18 B	$ 5.25	-0.57 %	$ 1.17 B	USA
China SXT Pharmaceuticals SXTC	5.69 M	$ 1.32	-5.2 %	$ 1.88 M	China
Bellerophon Therapeutics BLPH	77.1 M	-	-74.18 %	$ 955 K	USA
Kala Pharmaceuticals KALA	13.7 M	$ 0.2	-6.67 %	$ 759 K	USA
Tarsus Pharmaceuticals TARS	2.95 B	$ 67.2	0.36 %	$ 2.81 B	USA
CRISPR Therapeutics AG CRSP	4.38 B	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	847 M	$ 4.45	-1.77 %	$ 853 M	Canada
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	515 K	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA